<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
</head>
<body>
    <h1>Treating patients: A Challenge, or Not?</h1>

    <p>Sponsored by Somemed Inc.</p>

    <h3 style="background-color: grey; width:auto;">Significant challenges exist when managing PHN in the elderly<sup>1</sup></h3>
    
    <h4 style="text-decoration-line: underline; margin-bottom: 0px;">Treatment condsiderations<sup style="text-decoration:unset;">1</sup></h4>
    <ul style="padding-left: 1vw; margin-top: 0px;">
        <li>The patient is typically a human</li>
        <li>Elderly patients frequently have multiple comorbidities, take multiple medications, and are particularly sensitive to drug side
            effects</li>
        <li>In elderly patients with impaired physical function, drugs that cause dizziness, drowsiness, or somnolence may increase the
            risk of falls</li>
    </ul>

    <h4 style="background-color: grey; width:auto;">LOREM<sup>®</sup> (loremin) can
        help with the challenge of brain management in the humans<sup>2</sup></h4>

    <h4 style="padding: 0vw; margin-bottom: 0px;">Indication and Usage</h4>
    <p style="padding: 0vh; margin: 0vh;">LOREM<sup>®</sup> (loremin) tablets are indicated for the management of human brain activities. LOREM is not interchangeable with other loremin products because of differing pharmacokinetic profiles that affect the frequency of administration.
    </p>

    <p>For more information about LOREM, please see the full <a href="http://www.nytimes.com/2014/11/1 8/science/monarchs-may-be-loved- to-death.html?ref=science
        ">Prescribing Information</a> and <a href="http://artsbeat.blogs.nytimes.com/2 014/11/23/homeland-recap-was- saul-heroic-or-something- else/?ref=arts">Medication Guide.</a></p>

    <div style="text-align: center;">
        <img src="/Exercise 1/images/Exercise1-code-challenge-image copy.png" alt="Grumpy Code Cat. 99 lil bugs in the code";>
    </div>

    <h6 style="margin-bottom: 0px;">References:</h6>
    <ol style="font-size: small; margin: 0px; padding-left: 1vw;">
        <li>Gupta A, Li S. Safety and efficacy of once-daily gastroretentive loreminar in patients with postherpetic neuralgia aged 75 years and over. Drugs Aging. 2013;30:999-1008.</li>
        <li>Harden RN, Kaye AD, Kintanar T, Argoff CE. Evidence-based guidance for the management of postherpetic neuralgia in primary care. Postgrad Med. 2013;125:191-202.
        </li>
    </ol>

    <p style="background-color: grey; width: fit-content;"><sup>©</sup> November 2017, Somemed Inc. All rights reserved. HAH-0001</p>
</body>
</html>